Form 8-K - Current report:
SEC Accession No. 0001513162-19-000082
Filing Date
2019-03-27
Accepted
2019-03-27 08:30:38
Documents
3
Period of Report
2019-03-27
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K form8k.htm 8-K 24333
2 EXHIBIT 99.1 exhibit99_1.htm EX-99.1 9422
3 GRAPHIC graphic.jpg GRAPHIC 10121
  Complete submission text file 0001513162-19-000082.txt   43830
Mailing Address 290 UTAH AVE., SUITE 200 SOUTH SAN FRANCISCO CA 94080
Business Address 290 UTAH AVE., SUITE 200 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35285 | Film No.: 19706706
SIC: 2836 Biological Products, (No Diagnostic Substances)